Position in OGN
as of Jun 30, 2026
· filed Aug 11, 2026
Position Value
$476,526
+$263,917 QoQ
Shares Held
35,194
-0.8% QoQ
Ownership
0.013%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#188
of 626 holders
Holding Since
Mar 2025
6 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in OGN Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Summit Trail Advisors, LLC holds $121,589,141 across 15 Drug Manufacturers - General names. OGN ranks #15 (0.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
29,075 | $34,873,430 | |
| 2 | JNJ |
Johnson & Johnson
|
102,279 | $25,975,797 | |
| 3 | ABBV |
AbbVie Inc.
|
66,840 | $16,819,617 | |
| 4 | MRK |
Merck & Co., Inc.
|
84,812 | $10,898,342 | |
| 5 | AMGN |
Amgen Inc
|
16,519 | $5,981,860 | |
| 6 | GILD |
Gilead Sciences, Inc.
|
43,955 | $5,553,274 | |
| 7 | PFE |
Pfizer Inc
|
209,089 | $5,034,863 | |
| 8 | BMY |
Bristol Myers Squibb Co
|
71,425 | $4,115,508 |
All Filings in OGN
Export CSV
6 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $476,526 | 35,194 | Shares | Sole | 2026-08-11 | |
| 2026-03-31 | $212,609 | 35,494 | Shares | Sole | 2026-05-12 | |
| 2025-12-31 | $391,360 | 54,583 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $241,784 | 22,639 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $180,222 | 18,618 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $185,008 | 12,425 | Shares | Sole | 2025-04-28 | |
| No filing history on record for this holder in this stock. | ||||||